ProShare Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8K | Sell |
13,561
-27,601
| -67% | -$26.1K | ﹤0.01% | 2077 |
|
|
2025
Q1 | $19K | Sell |
41,162
-8,298
| -17% | -$3.82K | ﹤0.01% | 2042 |
|
|
2024
Q4 | $36.5K | Buy |
49,460
+6,404
| +15% | +$4.73K | ﹤0.01% | 2218 |
|
|
2024
Q3 | $67.6K | Buy |
43,056
+8,331
| +24% | +$13.1K | ﹤0.01% | 1941 |
|
|
2024
Q2 | $58.3K | Buy |
34,725
+979
| +3% | +$1.65K | ﹤0.01% | 1728 |
|
|
2024
Q1 | $81K | Buy |
33,746
+2,764
| +9% | +$6.63K | ﹤0.01% | 1851 |
|
|
2023
Q4 | $47.4K | Buy |
30,982
+2,933
| +10% | +$4.49K | ﹤0.01% | 1869 |
|
|
2023
Q3 | $30.6K | Buy |
28,049
+3,734
| +15% | +$4.07K | ﹤0.01% | 1758 |
|
|
2023
Q2 | $55.7K | Buy |
24,315
+1,429
| +6% | +$3.27K | ﹤0.01% | 1763 |
|
|
2023
Q1 | $55.6K | Sell |
22,886
-3,438
| -13% | -$8.35K | ﹤0.01% | 1661 |
|
|
2022
Q4 | $50.3K | Buy |
26,324
+1,699
| +7% | +$3.25K | ﹤0.01% | 1736 |
|
|
2022
Q3 | $59K | Buy |
24,625
+4,793
| +24% | +$11.5K | ﹤0.01% | 1644 |
|
|
2022
Q2 | $37K | Sell |
19,832
-8,703
| -30% | -$16.2K | ﹤0.01% | 1735 |
|
|
2022
Q1 | $60K | Sell |
28,535
-7,722
| -21% | -$16.2K | ﹤0.01% | 2101 |
|
|
2021
Q4 | $143K | Buy |
+36,257
| New | +$143K | ﹤0.01% | 2138 |
|
|
2021
Q3 | – | Sell |
-17,612
| Closed | -$81K | – | 2146 |
|
|
2021
Q2 | $81K | Buy |
17,612
+4,323
| +33% | +$19.9K | ﹤0.01% | 2316 |
|
|
2021
Q1 | $78K | Buy |
+13,289
| New | +$78K | ﹤0.01% | 2189 |
|
|
2020
Q4 | – | Sell |
-22,321
| Closed | -$32K | – | 2098 |
|
|
2020
Q3 | $32K | Sell |
22,321
-381
| -2% | -$546 | ﹤0.01% | 1614 |
|
|
2020
Q2 | $45K | Buy |
22,702
+5,629
| +33% | +$11.2K | ﹤0.01% | 1629 |
|
|
2020
Q1 | $33K | Sell |
17,073
-11,534
| -40% | -$22.3K | ﹤0.01% | 1130 |
|
|
2019
Q4 | $119K | Sell |
28,607
-4,889
| -15% | -$20.3K | ﹤0.01% | 1675 |
|
|
2019
Q3 | $101K | Sell |
33,496
-2,102
| -6% | -$6.34K | ﹤0.01% | 1548 |
|
|
2019
Q2 | $224K | Sell |
35,598
-5,085
| -12% | -$32K | ﹤0.01% | 1376 |
|
|
2019
Q1 | $226K | Buy |
40,683
+241
| +0.6% | +$1.34K | ﹤0.01% | 1395 |
|
|
2018
Q4 | $269K | Sell |
40,442
-8,022
| -17% | -$53.4K | ﹤0.01% | 1209 |
|
|
2018
Q3 | $517K | Sell |
48,464
-1,703
| -3% | -$18.2K | ﹤0.01% | 1087 |
|
|
2018
Q2 | $602K | Sell |
50,167
-4,160
| -8% | -$49.9K | ﹤0.01% | 1030 |
|
|
2018
Q1 | $466K | Sell |
54,327
-8,954
| -14% | -$76.8K | ﹤0.01% | 1125 |
|
|
2017
Q4 | $625K | Buy |
63,281
+851
| +1% | +$8.41K | ﹤0.01% | 1026 |
|
|
2017
Q3 | $767K | Buy |
62,430
+4,604
| +8% | +$56.6K | 0.01% | 804 |
|
|
2017
Q2 | $951K | Sell |
57,826
-2,574
| -4% | -$42.3K | 0.01% | 747 |
|
|
2017
Q1 | $866K | Sell |
60,400
-15,119
| -20% | -$217K | 0.01% | 800 |
|
|
2016
Q4 | $1.04M | Buy |
75,519
+4,517
| +6% | +$62.4K | 0.01% | 754 |
|
|
2016
Q3 | $1.28M | Sell |
71,002
-11,451
| -14% | -$207K | 0.02% | 622 |
|
|
2016
Q2 | $1.18M | Buy |
82,453
+663
| +0.8% | +$9.51K | 0.02% | 668 |
|
|
2016
Q1 | $977K | Sell |
81,790
-7,592
| -8% | -$90.7K | 0.01% | 705 |
|
|
2015
Q4 | $1.19M | Buy |
89,382
+6,390
| +8% | +$85.1K | 0.01% | 669 |
|
|
2015
Q3 | $891K | Sell |
82,992
-5,039
| -6% | -$54.1K | 0.01% | 710 |
|
|
2015
Q2 | $709K | Sell |
88,031
-2,258
| -3% | -$18.2K | 0.01% | 937 |
|
|
2015
Q1 | $597K | Buy |
90,289
+33,908
| +60% | +$224K | 0.01% | 1096 |
|
|
2014
Q4 | $359K | Buy |
56,381
+5,533
| +11% | +$35.2K | ﹤0.01% | 1387 |
|
|
2014
Q3 | $502K | Sell |
50,848
-9,703
| -16% | -$95.8K | 0.01% | 1405 |
|
|
2014
Q2 | $682K | Sell |
60,551
-28,485
| -32% | -$321K | 0.01% | 1381 |
|
|
2014
Q1 | $1.08M | Buy |
89,036
+54,448
| +157% | +$659K | 0.01% | 1247 |
|
|
2013
Q4 | $436K | Sell |
34,588
-11,695
| -25% | -$147K | 0.01% | 1085 |
|
|
2013
Q3 | $768K | Buy |
46,283
+12,750
| +38% | +$212K | 0.02% | 1078 |
|
|
2013
Q2 | $509K | Buy |
+33,533
| New | +$509K | 0.01% | 1323 |
|